BCM
CRL icon

Bayesian Capital Management’s Charles River Laboratories CRL Stock Holding History

Bayesian Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,602
Closed -$4.04M – 585
2025
Q2 		$4.04M Buy
+26,602
New +$3.55M 0.64% 32
2025
Q1 		– Sell
-17,965
Closed -$3.32M – 669
2024
Q4 		$3.32M Buy
+17,965
New +$3.46M 0.41% 63
2024
Q3 		– Sell
-2,430
Closed -$502K – 745
2024
Q2 		$502K Buy
+2,430
New +$551K 0.06% 368
2024
Q1 		– Sell
-870
Closed -$206K – 830
2023
Q4 		$206K Buy
+870
New +$171K 0.02% 596
2023
Q3 		– Sell
-1,300
Closed -$273K – 745
2023
Q2 		$273K Buy
+1,300
New +$259K 0.03% 562
2023
Q1 		– Sell
-7,100
Closed -$1.55M – 845
2022
Q4 		$1.55M Buy
+7,100
New +$1.55M 0.23% 97
2020
Q3 		– Sell
-6,100
Closed -$1.06M – 545
2020
Q2 		$1.06M Sell
6,100
-2,700
-31% -$431K 0.23% 119
2020
Q1 		$1.11M Buy
+8,800
New +$1.32M 0.24% 104
2019
Q3 		– Sell
-2,128
Closed -$302K – 543
2019
Q2 		$302K Sell
2,128
-2,700
-56% -$366K 0.06% 356
2019
Q1 		$701K Buy
+4,828
New +$634K 0.13% 216
2017
Q2 		– Sell
-6,566
Closed -$591K – 456
2017
Q1 		$591K Buy
+6,566
New +$558K 0.28% 123

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bayesian Capital Management's CRL Position: Q3 2025 in Review

Bayesian Capital Management sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 26,602 shares — an estimated $4.04M sold.

Bayesian Capital Management first reported a position in CRL in Q1 2017 and held it in 11 quarters. The position peaked at $4.04M in Q2 2025. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Bayesian Capital Management reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 26,602 Charles River Laboratories shares in Q3 2025, an estimated $4.04M.
  • Bayesian Capital Management first reported a position in Charles River Laboratories in Q1 2017 and held it in 11 quarters.
  • Bayesian Capital Management's Charles River Laboratories position peaked at $4.04M in Q2 2025.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.